|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ribeiro Pereira ACP, Koifman RJ and
Bergmann A: Incidence and risk factors of lymphedema after breast
cancer treatment: 10 years of follow-up. Breast. 36:67–73. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lemler DJ, Lynch ML, Tesfay L, Deng Z,
Paul BT, Wang X, Hegde P, Manz DH, Torti SV and Torti FM: DCYTB is
a predictor of outcome in breast cancer that functions via
iron-independent mechanisms. Breast Cancer Res. 19:252017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cuzick J, DeCensi A, Arun B, Brown PH,
Castiglione M, Dunn B, Forbes JF, Glaus A, Howell A, von Minckwitz
G, et al: Preventive therapy for breast cancer: A consensus
statement. Lancet Oncol. 12:496–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weigelt B, Peterse JL and van't Veer LJ:
Breast cancer metastasis: Markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu YP, Jin YP, Wu XS, Yang Y, Li YS, Li
HF, Xiang SS, Song XL, Jiang L, Zhang YJ, et al: LncRNA-HGBC
stabilized by HuR promotes gallbladder cancer progression by
regulating miR-502-3p/SET/AKT axis. Mol Cancer. 18:1672019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin C and Yang L: Long noncoding RNA in
cancer: Wiring signaling circuitry. Trends Cell Biol. 28:287–301.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Wang P, Cao L, Li F, Duan S, Yuan
G, Xiao L, Guo L, Yin H, Xie D, et al: Long intergenic non-coding
RNA 01121 promotes breast cancer cell proliferation, migration, and
invasion via the miR-150-5p/HMGA2 axis. Cancer Manag Res.
11:10859–10870. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo S, Jian L, Tao K, Chen C, Yu H and Liu
S: Novel breast-specific long non-coding RNA LINC00993 acts as a
tumor suppressor in triple-negative breast cancer. Front Oncol.
9:13252019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu Q, Li C, Wang S, Li Y, Wen B, Zhang Y,
Liang K, Yao J, Ye Y, Hsiao H, et al: LncRNAs-directed PTEN
enzymatic switch governs epithelial-mesenchymal transition. Cell
Res. 29:286–304. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin C, Yan B, Lu Q, Lin Y and Ma L:
Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1
promotes triple-negative breast cancer development. Tumour Biol.
37:7383–7394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu X, Gu J, Ding X, Ge G, Zang X, Ji R,
Shao M, Mao Z, Zhang Y, Zhang J, et al: LINC00978 promotes the
progression of hepatocellular carcinoma by regulating EZH2-mediated
silencing of p21 and E-cadherin expression. Cell Death Dis.
10:7522019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qian H, Chen L, Huang J, Wang X, Ma S, Cui
F, Luo L, Ling L, Luo K and Zheng G: The lncRNA MIR4435-2HG
promotes lung cancer progression by activating β-catenin
signalling. J Mol Med (Berl). 96:753–764. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X, Ren Y and Zuo T: Long noncoding RNA
LINC00978 promotes cell proliferation and invasion in nonsmall cell
lung cancer by inhibiting miR-6754-5p. Mol Med Rep. 18:4725–4732.
2018.PubMed/NCBI
|
|
17
|
Wang H, Wu M, Lu Y, He K, Cai X, Yu X, Lu
J and Teng L: LncRNA MIR4435-2HG targets desmoplakin and promotes
growth and metastasis of gastric cancer by activating Wnt/β-catenin
signaling. Aging (Albany NY). 11:6657–6673. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo P, Wu SG, Ji KB, Yuan X, Li HM, Chen
JP, Tian YF, Qiu Y and Zhong XM: LncRNA MIR4435-2HG mediates
cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1.
PLoS One. 15:e02230352020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu LJ, Wang AH, Gao M, Duan XY and Li ZH:
LncRNA MIR4435-2HG triggers ovarian cancer progression by
regulating miR-128-3p/CKD14 axis. Cancer Cell Int. 20:1452020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng LL, Chi YY, Liu L, Huang NS, Wang L
and Wu J: LINC00978 predicts poor prognosis in breast cancer
patients. Sci Rep. 6:379362016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pohl SG, Brook N, Agostino M, Arfuso F,
Kumar AP and Dharmarajan A: Wnt signaling in triple-negative breast
cancer. Oncogenesis. 6:e3102017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu S, Qiao Z, Ma Q, Liu X and Ma X:
LncRNA CYTOR and MIR4435-2HG in ovarian cancer and its relationship
with clinicopathological features. Panminerva Med. 2019.(Epub ahead
of print).
|
|
25
|
Zhang H, Meng H, Huang X, Tong W, Liang X,
Li J, Zhang C and Chen M: lncRNA MIR4435-2HG promotes cancer cell
migration and invasion in prostate carcinoma by upregulating
TGF-β1. Oncol Lett. 18:4016–4021. 2019.PubMed/NCBI
|
|
26
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
McIlwain DR, Berger T and Mak TW: Caspase
functions in cell death and disease. Cold Spring Harb Perspect
Biol. 5:a0086562013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Degterev A, Boyce M and Yuan J: A decade
of caspases. Oncogene. 22:8543–8567. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suliman A, Lam A, Datta R and Srivastava
RK: Intracellular mechanisms of TRAIL: Apoptosis through
mitochondrial-dependent and -independent pathways. Oncogene.
20:2122–2133. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang YP, Guo PT, Zhu Z, Zhang H, Xu Y,
Chen YZ, Liu F and Ma SP: Pleomorphic adenoma gene like-2 induces
epithelial-mesenchymal transition via Wnt/β-catenin signaling
pathway in human colorectal adenocarcinoma. Oncol Rep.
37:1961–1970. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang P, Zhao X, Zhang W, He A, Lei B,
Zhang W and Chen Y: Leukemia-associated gene MLAA-34 reduces
arsenic trioxide-induced apoptosis in HeLa cells via activation of
the Wnt/β-catenin signaling pathway. PLoS One. 12:e01868682017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shao HM, Ma JH, Guo TH and Hu RR:
Triptolide induces apoptosis of breast cancer cells via a mechanism
associated with the Wnt/β-catenin signaling pathway. Exp Ther Med.
8:505–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Knobloch J, Schmitz I, Götz K,
Schulze-Osthoff K and Rüther U: Thalidomide induces limb anomalies
by PTEN stabilization, akt suppression, and stimulation of
caspase-dependent cell death. Mol Cell Biol. 28:529–538. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang M, He X, Huang X, Wang J, He Y and
Wei L: LncRNA MIR4435-2HG-mediated upregulation of TGF-beta1
promotes migration and proliferation of nonsmall cell lung cancer
cells. Environ Toxicol. 35:582–590. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kong Q, Liang C, Jin Y, Pan Y, Tong D,
Kong Q and Zhou J: The lncRNA MIR4435-2HG is upregulated in
hepatocellular carcinoma and promotes cancer cell proliferation by
upregulating miRNA-487a. Cell Mol Biol Lett. 24:262019. View Article : Google Scholar : PubMed/NCBI
|
